Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus brevis SBC8803 and Improved Skin Barrier Function

Research synthesisLow evidenceSmall effect5 studies · 5 beneficial · 0 neutral · 0 harmful

Across 5 studies, all reported beneficial effects of Lactobacillus brevis SBC8803 on skin barrier function, with effect sizes predominantly small. One meta-analysis found a statistically significant small effect on reducing trans-epidermal water loss (pSMD = -0.50, p = 6.39 × 10⁻⁴). Doses were not reported in the available studies, and the evidence primarily comes from reviews and a meta-analysis covering general healthy adults and some patient populations.

  • Studied populations: healthy adults; patients with psoriasis (one review); general adult population in skin aging studies (meta-analysis)

Caveats: Only one study (a meta-analysis) provides a statistically significant finding with a reported effect size; the remaining four are narrative reviews with no original quantitative data. Doses are not specified in any included study. Evidence is largely indirect or preliminary, and most studies are not specifically focused on Lactobacillus brevis SBC8803 but rather on probiotics or dietary interventions more broadly.

Generated May 11, 2026
6 of 6 papers
Back to top